This antibody reacts with the CD9-antigen, which is expressed on the surface of developing B lymphocytes, platelets, monocytes, eosinophils, basophils, stimulated T lymphocytes and by neurons and glial cells in the peripheral nervous system. In pre-B cells and platelets, CD9 antigen regulates cell activation and aggregation possibly through an association with the integrin CD41/CD61 (GPIIb/GPIIIa).
The reagent is provided in aqueous buffered solution containing protein stabilizer, and ≤0.09% sodium Azide (NaN3).
Immunogen
Tissue / cell preparation (Human): Pre B cell line NALM-6.Please refer to the Certificate of Analysis for the lot-specific concentration. Typically 0,05 mg/ml.
Concentration
Please refer to the Certificate of Analysis for the lot-specific concentration. Typically 0,05 mg/ml.
Recomended usage
CD9, clone VJ1/20, is a mAb intended for the identification/ enumeration of human platelets using FCM. This reagent is effective for direct IF staining of human tissue for FCM analysis using ≤1 μg/10^6 cells.